Covance

Activities: Research & Development

Trending Articles

  1. Sanofi opens €558m modular vaccine and biologics manufacturing facility in Singapore The biopharmaceutical manufacturing facility will allow Sanofi to manufacture up to four vaccines and biologic medicines simultaneously, while also enhancing the area's...
  2. Pfizer appoints Chris Boshoff as Chief Scientific Officer and President of R&D Dr Boshoff will be responsible for overseeing and advancing Pfizer's R&D initiatives across all therapeutic areas
  3. Ingenza and HydRegen collaborate to optimise biomanufacturing sustainability The companies will work together to optimise and scale HydRegen's range of amine-based biocatalysts, which are more sustainable and cost-effective than traditional metal catalysts
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    The new fight against diabetes and obesity Incretin mimetics administered by autoinjectors or pens enable significant weight reduction and offer an important way to combat obesity and prevent type 2 diabetes. As such,...
  5. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

Related Content

Media

Pharma outsourcing mergers and acquisitions set for record year in 2015

Value of pharmaceutical outsourcing merger and acquisition deals has more than doubled from US$5.5bn in 2014 to $12bn by October 2015
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development

Focus turns to pre-empting disease causes and ageing

Drug discovery is brimming with innovation and technology but success is still seldom and slow. Susan Birks reports on the changing discovery landscape and how the odds can be improved
Manufacturing

Covance expands global biologics capabilities

New investments in facilities and scientific leadership reflect commitment to biologics development
Analysis

Covance and PathoQuest collaborate on NGS-based biosafety assessments

Innovative biosafety testing approach provides a flexible testing solution to all biotherapeutic clients
Regulatory

Covance and Indiana Clinical and Translational Sciences Institute to conduct early clinical trials

Two organisations will conduct high-quality research in a safe and regulated environment for sponsors who are looking to recruit both healthy volunteers and patients
Regulatory

Steve Street joins Covance

Will oversee worldwide safety assessment and pharmaceutical chemistry services
Finance

Covance and sanofi-aventis finalise r&d alliance

Covance also acquires sanofi-aventis plants in France and the UK
Subscribe now